Nov 16, 2021 09:01AM
Oct 22, 2021 09:55AM
Oct 22, 2021 09:55AM
Jun 22, 2021 09:00AM
Apr 12, 2021 01:57PM
Mar 31, 2021 03:40AM
Feb 26, 2021 09:20AM Biofrontera AG announces the closing of the capital raise with gross proceeds of EUR 24.7 million
Feb 24, 2021 08:30AM
Feb 24, 2021 05:57AM
Feb 23, 2021 07:54PM
Nov 11, 2020 07:00AM
Oct 8, 2020 11:07AM
Oct 8, 2020 11:04AM
Aug 26, 2020 09:51AM Biofrontera report results for the first six months of 2020
May 19, 2020 10:15AM
Apr 20, 2020 11:06AM
Feb 19, 2020 05:45AM
Feb 3, 2020 06:39AM
Feb 3, 2020 05:45AM
Feb 3, 2020 05:45AM
Nov 19, 2019 03:25AM Biofrontera Reports Third Quarter 2019 Financial Results and Revises Guidance
Sep 17, 2019 05:57AM
Sep 17, 2019 05:45AM
Aug 27, 2019 02:15AM
Aug 5, 2019 09:00AM
May 29, 2019 03:11AM
Apr 29, 2019 02:00AM
Apr 16, 2019 07:30AM Biofrontera reports further positive results from the phase III trial with Ameluz® for photodynamic therapy of actinic keratoses on the extremities and trunk/neck
Mar 25, 2019 11:30AM
Mar 25, 2019 10:00AM
Mar 20, 2019 10:52AM
Mar 20, 2019 10:50AM
Jan 8, 2019 02:02AM
Nov 16, 2018 02:20AM
Sep 26, 2018 06:11AM Biofrontera AG (BFRA) Commences Patient Enrollment for U.S. Phase III Trial Evaluating Ameluz / BF-RhodoLED for Superficial Basal Cell Carcinoma
Sep 26, 2018 03:15AM
Sep 3, 2018 05:35AM
May 30, 2018 08:00AM
Apr 30, 2018 08:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All